美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Definium Therapeutics

34.23

-0.9745-2.77%

成交量：7.52万

成交额：259.67万

市值：45.99亿

市盈率：-9.83

高：34.84

开：34.83

低：34.03

收：35.20

52周最高：49.70

52周最低：10.46

股本：1.34亿

流通股本：1.30亿

量比：0.50

换手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-3.4823

每股收益(LYR):-2.0600

净资产收益率：-64.09%

总资产收益率：-20.64%

市净率：5.01

市盈率(LYR):-16.61

数据加载中...

总览公司新闻资讯公告

摩根大通对基于LSD的疗法给予“超配”评级，Definium股价上涨

BUZZ——美国股市动态-SpaceX、Humana、达美航空

摩根大通首次覆盖Definium Therapeutics给予增持评级，盘前股价应声上涨4%

Definium Therapeutics股价盘前上涨4%，此前摩根大通首次覆盖该股并给予增持评级。

专家敦促美国食品药品监督管理局（FDA）为迷幻药物制定明确的安全和获取标准

Definium Therapeutics股价盘前飙升20%，其LSD类抗焦虑药物在第二项晚期研究中再次取得成功

Definium公司基于LSD的药物在第二项成功的后期临床研究中降低了焦虑水平

Definium Therapeutics：DT120口崩片III期全景研究在广泛性焦虑障碍中达成主要及关键次要终点

Definium Therapeutics：DT120口腔崩解片100微克总体耐受性良好，安全性特征一致，未现新型安全信号

Definium Therapeutics：DT120口崩片100微克在12周时显示安慰剂校正的汉密尔顿焦虑量表评分降低5.1分

Definium Therapeutics将于2026年9月14日公布泛发性焦虑障碍III期Panorama研究的关键结果

Definium因抑郁症药物获FDA“突破性疗法”认定而股价上涨

Definium Therapeutics 重磅消息：DT120（麦角酸二乙胺）口崩片获突破性疗法认定，三期临床数据亮眼

市场快讯——美股行情动态-Sutro Biopharma、Humacyte

Definium Therapeutics 焦虑症药物晚期试验达标，盘前股价飙升 22%

Definium Therapeutics股价上涨，因其治疗焦虑症的药物达到了后期临床试验的目标

Definium Therapeutics 宣布DT120 Odt针对广泛性焦虑障碍的3期Voyage研究取得积极顶线结果

Definium Therapeutics：DT120 Odt 三期Voyage研究达成主要及关键次要疗效终点

Definium公司表示，基于LSD的药片在晚期临床试验中可缓解焦虑

Definium Therapeutics：DT120 Odt 在研究中总体耐受性良好，未出现包括自杀倾向信号在内的新安全性信号

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/DFTX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":34.2255,"timestamp":1791899736216,"preClose":35.2,"halted":0,"volume":75216,"delay":0,"changeRate":-0.027684659090909263,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"交易中","change":-0.9745,"latestTime":"10-13 09:55:37 EDT","open":34.83,"high":34.84,"low":34.03,"amount":2596652.63376,"amplitude":0.023011,"askPrice":34.25,"askSize":40,"bidPrice":34.16,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.2,"preHourTrading":{"tag":"盘前","latestPrice":34.79,"preClose":35.2,"latestTime":"09:29 EDT","volume":3323,"amount":117173.485988,"timestamp":1791898199999,"change":-0.41,"changeRate":-0.011648,"amplitude":0.03033},"postHourTrading":{"tag":"盘后","latestPrice":35.37,"preClose":35.2,"latestTime":"19:30 EDT","volume":15544,"amount":547087.5145,"timestamp":1791847803321,"change":0.17,"changeRate":0.00483,"amplitude":0.01108},"volumeRatio":0.502072,"impliedVol":0.5156,"impliedVolPercentile":0.0054},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.502072,"shares":134366950,"dividePrice":0,"high":34.84,"amplitude":0.023011,"preClose":35.2,"low":34.03,"week52Low":10.4646,"pbRate":"5.01","week52High":49.7,"institutionHeld":0,"latestPrice":34.2255,"committee":0.428571,"eps":-3.482311,"divideRate":0,"volume":75216,"delay":0,"ttmEps":-3.482311,"open":34.83,"prevYearClose":13.39,"prevWeekClose":36.9,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":35.62,"twentyDayClose":36.82,"sixtyDayClose":42.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787198400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-12","current":-9.828387,"percent":0.375,"low":-27.074722,"twenty":-17.026359,"median":-11.77112,"eighty":-9.952097,"high":-8.802064,"avg":-13.971462,"sd":5.091426,"marketCap":4958140455},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320},{"date":"2026-10-09","current":-12.981507,"twenty":-17.033955,"median":-11.725012,"eighty":-9.950275,"marketCap":4592662351},{"date":"2026-10-12","current":-14.014558,"twenty":-17.026359,"median":-11.77112,"eighty":-9.952097,"marketCap":4958140455}],"updateTime":1791899737828},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674689988","title":"摩根大通对基于LSD的疗法给予“超配”评级，Definium股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2674689988","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674689988?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 23:00","pubTimestamp":1791558057,"startTime":"0","endTime":"0","summary":"BUZZ-摩根大通对基于LSD的疗法给予“超配”评级，Definium股价上涨最新动态10月9日-** Definium Therapeutics（DFTX.O）股价上涨7.4%，报36.7美元** 若涨势得以维持，该股有望创下自6月以来的最大单日涨幅** 摩根大通首次覆盖该股，给予“增持”评级，目标价84美元** 该券商表示，Definium的领先候选药物DT120 ODT有望改变神经精神疾病的","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4T45V155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674592758","title":"BUZZ——美国股市动态-SpaceX、Humana、达美航空","url":"https://stock-news.laohu8.com/highlight/detail?id=2674592758","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674592758?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 19:57","pubTimestamp":1791547060,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-SpaceX、Humana、达美航空工作区中用于查询单只股票走势的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透10月9日-周五，随着中东供应担忧缓解导致油价回落，美国股指期货上涨；但SpaceX收购频谱引发了整个电信行业的竞争担忧，电信股仍承压。.N** ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4S45V0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","SGXZ81514606.USD","LU0345769128.USD","IE00BLSP4452.SGD","LU1153585028.USD","LU0957791311.USD","KBWB","LU2896262040.SGD","LU0823416689.USD","LU0654597011.USD","AAPX","JPMO","LU0122379950.USD","LU1582987597.SGD","LU1791710400.SGD","LU0788109477.HKD","GB00BDT5M118.USD","SG9999014575.USD","LU1066053197.SGD","GDX","FNCL","LU0211327993.USD","LU1718418525.SGD","LU0965508806.USD","SG9999014013.SGD","LU2242650005.HKD","LU0109392836.USD","IE00BJT1NW94.SGD","IE00BBT3K403.USD","LU0432979614.USD","CMAG","LU1917777945.USD","BK4213","IE00BWXC8680.SGD","HK0000320223.HKD","LU0345770993.USD","LU1778281490.HKD","LU1035773651.USD","LU1642822529.SGD","NWMX","LU2077746001.SGD","SAAPLmain","IE00B1XK9C88.USD","IE00BDCRKT87.USD","LU0787776722.HKD","SPCX","LU0070302665.USD","IE00BKPKM429.USD","LU0070217475.USD","LU0965509101.SGD","LU2237443382.USD","LU2265009873.SGD","SG9999015945.SGD","LU0314104364.USD","LU0689626769.HKD","LU2506951875.HKD","LU0187121727.USD","IE00BQXX3F31.USD","LOFF","SG9999015341.SGD","LU0889565833.HKD","LU0310800965.SGD","BK4007","LU0942090050.USD","IE00BQXX3C00.GBP","XLV","SG9999013999.USD","BK4515","LU1815336760.USD","LU2430703095.HKD","SGXZ57979304.SGD","LU1582986433.USD","BK4207","LU2111349929.HKD","LU0719512351.SGD","IE00B3SWFQ91.USD","LU0820561909.HKD","IE00B775SV38.USD","IXG","LU0683600562.USD","LU0251131958.USD","LU2097344431.USD","IE000SO60NU8.SGD","LU1974910355.USD","LU1861215975.USD","LU0256863811.USD","LU0215105999.USD","LU0342679015.USD","LU2491050154.USD","LU2125154778.USD","SPTE","LU1804176565.USD","IE00BK4W5M84.HKD","FTEC","BK4533","BK4154","LU1316542783.SGD","SPCU","LU0859254822.USD","LU0354030511.USD","LU0310800379.SGD","LU1223082196.USD","IE00BQXX3D17.EUR","LU2462611646.USD","LU0029864427.USD","VGT","IE0005OL40V9.USD","LU0109391861.USD","IE0004091025.USD","LU0289739343.SGD","LU0133085943.USD","LU0354030438.USD","LU2089284900.SGD","LU0708994859.HKD","LU2097344357.USD","JPM","LU2471134879.HKD","AAPY","LU2506951958.HKD","LU0348723411.USD","LU2089984988.USD","LU0310799852.SGD","LU1244550221.USD","LU0106831901.USD","LU2168564495.EUR","LU0234572021.USD","LU1235294995.USD","IE000YTNTUN2.SGD","LU2250418816.HKD","BK4008","FMTL","IE00B4R5TH58.HKD","IE00BJTD4V19.USD","LU2362540622.SGD","LU0345768740.USD","LU0417517546.SGD","SGXZ99366536.SGD","LU2543165471.USD","LU1206713676.USD","LU1988902786.USD","IE0002270589.USD","LU2357305700.SGD","LU1366333091.USD","LU2506952097.USD","LU0289739699.SGD","AAPU","LU2125154935.USD","LU1202635105.USD","LU1621768206.USD","LU1162221912.USD","BK4598","LU0971096721.USD","LU0256863902.USD","LU1363072403.SGD","LU1629891620.HKD","LU1232071149.USD","YSPC","UNHU","IE000M9KFDE8.USD","LU2552382132.HKD","LU0234570918.USD","LU1280957306.USD","IHF","SG9999015986.USD","LU0689472784.USD","LU2065171311.SGD","VHT","LU0345769631.USD","SG9999002224.SGD","LU0553294199.USD","BK4585","IYH","LU1116320901.HKD","LU1430597077.USD","LU2430703251.USD","FHLC","LU1066051225.USD","LU1935042991.SGD","LU2133065610.SGD","LU2403377893.USD","LU0957808578.USD","LU1046421795.USD","LU1935042488.USD","LU2237443622.USD","HK0000914660.USD","LU0320765646.SGD","LU0494093205.USD","LU1571399168.USD","LU2317271919.USD","LU2360032135.SGD","LU0210536198.USD","SGXZ80539844.SGD","LU2361044865.SGD","BK4534","IE00BKDWB100.SGD","WSPC","LU0784385840.USD","LU0472753341.HKD","BK4522","HK0000914686.HKD","IE0034235303.USD","LU0157215616.USD","LU1084165304.USD","NEM","IE00BK4W5L77.USD","LU1206712785.SGD","LU0823417653.USD","LU1720051017.SGD","SG9999002232.USD","SGXZ31699556.SGD","LU0143551892.USD","IE00BFXG1179.USD","LU2236285917.USD","BK4505","LU0868494617.USD","IE00B19Z9Z06.USD","LU2505996509.AUD","LU0320765489.SGD","LU0511384066.AUD","VT","LU1668664300.SGD","IE00B19Z3581.USD","LU2347655156.SGD","UYG","BK4570","LU0266512473.USD","LU0661504455.SGD","LU0345780521.USD","LU0303821028.USD","LU1934455863.HKD","LU1242518931.SGD","LU1803068979.SGD","LU0080751232.USD","TMED","TMUS","SGDM","LU1989772840.SGD","IE00B19Z9505.USD","LU1868836757.USD","LU1699723380.USD","IE00BJTD4N35.SGD","LU1496350171.SGD","LU2746668461.USD","LU0162691827.USD","SG9999014542.SGD","LOFD","SPCQ","LU2487616109.SGD","LU0784383803.USD","LU0052756011.USD","LU1883866441.USD","LU0238689110.USD","LU1989764664.SGD","AUAU","LU2211815571.USD","LU2471134952.CNY","LU0251142724.SGD","LU0640476718.USD","LU2361045086.USD","LU0345780950.USD","LU0612318971.USD","LU0128525689.USD","LU0965509010.AUD","LU1861220033.SGD","TTXU","LU2087621335.USD","IE00B4JS1V06.HKD","BK4574","LU1854104046.USD","LU1037948897.HKD","LU0943347566.SGD","IE00BFSS7M15.SGD","LU0949170772.SGD","LU1037948541.HKD","LU0303823156.USD","LU2463028550.USD","LU2237438978.USD","LU0496365809.HKD","FTXO","LU0267386448.USD","LU1868837300.USD","LU0979878070.USD","BK4516","LU1839511570.USD","LU0114720955.EUR","LU0057025933.USD","HMY","LU1102505762.USD","LU2506952170.USD","AGMI","GFI","LU2244417387.USD","LU2381873111.SGD","LU2210150020.SGD","IE00BFTCPJ56.SGD","LU0174119429.USD","LU0788109121.HKD","LU0048573561.USD","BK4532","LU2168563687.JPY","SG9999014005.SGD","LU0061474705.USD","APLY","LU2452424414.USD","LU0265550359.USD","LU1023059493.AUD","SPCG","BK4575","LU0820561818.USD","LU0985320562.USD","LU1145028129.USD","LU2602419157.SGD","UN","LU1852331112.SGD","LU2290526834.HKD","LU2108987350.USD","LU1868837565.USD","VFH","LU0208291251.USD","LU1303367103.USD","LU0170899867.USD","BK4559","LU1144417596.USD","IE0009G5SDU7.USD","NEMG","LU0823417737.USD","SNK","LU0210533765.USD","LU2384288077.EUR","LU1366192091.USD","LU0861579265.USD","LU1496350502.SGD","LU2210149790.SGD","LU1645745479.HKD","IE000KEQY171.SGD","LU2637965513.SGD","SUNH0main","UNH","LU2168564065.EUR","IE00BFSS8Q28.SGD","LU2237443465.HKD","LU0097036916.USD","BK4549","LU0724618789.USD","LU2999663052.SGD","LU1061106388.HKD","LU2242649171.HKD","FXH","LU2324357040.USD","IE000MB6IJN5.SGD","LU0823421333.USD","LU0149725797.USD","LU1674673428.USD","LU0545039389.USD","SG9999015978.USD","LU0124676726.USD","SG9999014914.USD","LU2247934214.USD","LU2498475776.HKD","LU2756315664.SGD","LU2023251221.USD","SG9999015952.SGD","LU0158827948.USD","LU0276348264.USD","LU0053666078.USD","IE0009355771.USD","LU2471134796.USD","LU2458330169.SGD","LU2065171402.SGD","LU2750360997.AUD","LU0072461881.USD","GOAU","LU0061475181.USD","LU2362541273.HKD","LU1983260115.SGD","LU2095319765.USD","LU1989772923.USD","LU0300736492.USD","LU0345781412.USD","LU0198837287.USD","LU1069347547.HKD","LU0795875169.SGD","LU0300736062.USD","LU1267930490.SGD","IE000F7OJYX1.SGD","LU0265550946.USD","LU0266013472.USD","LU0353189680.USD","BK4573","HRTS","LU0158827781.USD","HK0000306685.HKD","LU0266512127.USD","LU2462591350.SGD","IXJ","IE00B1BXHZ80.USD","LU1732800096.USD","IE00BMPRXN33.USD","LU0498741114.HKD","LU1983299246.USD","UNHG","LU0314106906.USD","IOSX","LU2417539215.USD","LU1035775433.USD","BK4588","LU1400636574.HKD","MARS","SG9999014880.SGD","LU0096362180.USD","LU1934455194.USD","SPAX","LU0868494708.USD","BK4500","SPAL","ROM","TRUM","LU0950375773.USD","LU0786609619.USD","LU1551013425.SGD","IE00BDRTCR15.USD","LU1242518857.USD","IE00BHPRN162.USD","LU2023250843.SGD","LU0724617625.USD","HK0000304805.HKD","LU2462591277.SGD","LU1267930227.SGD","LU1861558580.USD","LU0726765562.USD","LU0912757837.SGD","LU1116320737.USD","LU1032466523.USD","IE00B19Z8W00.USD","LU1548497426.USD","LU1914381329.SGD","LU0069063385.USD","XLK","LU1814569148.SGD","LU0203347892.USD","LU1935042215.USD","LU1868837136.USD","LU0061474960.USD","LU1074936037.SGD","LU1935043536.SGD","LU0072462426.USD","GDMN","IE00BN8TJ469.HKD","LU1720051108.HKD","SG9999014906.USD","DFTX","SG9999018857.SGD","ABFL","LU0390134368.USD","SG9999001143.SGD","LU0368265764.SGD","IE00BJJMRY28.SGD","LU1400636491.USD","LU2592432038.USD","HK0000320264.USD","AAPL","LU2213496289.HKD","LU2092937148.SGD","LU2237443549.SGD","LU2360106780.USD","LU2286300806.USD","IE000Q6AESB8.SGD","LU2505996681.GBP","LU1323610961.USD","SPCH","LU1621767737.EUR","LU2168564149.EUR","LU2347655073.USD","UNHW","LU1064131342.USD","LU1823568750.SGD","LU1506573853.SGD","LU2456880835.USD","LU0708995401.HKD","GLDN","LU1057294990.SGD","TYLG","SLVP","IE00BYXW3230.USD","BK4501","LU2065169927.USD","LU1868838027.USD","LU2083900584.USD","LU2237443978.SGD","IE00B19Z8X17.USD","JDOC","LU1102505929.USD","IE00B894F039.SGD","LU0011850046.USD","IE00B19Z3B42.SGD","LU1670756490.USD","LU2264538146.SGD","JPO","LU0630314457.HKD","DAL","LU0096364046.USD","LU2362541513.USD","IE00B3T34201.USD","HK0000304797.USD","LU1093756168.USD","LU0964807845.USD","CRGY","HK0000819398.USD","MHIP","IE000BZT7R73.USD","ELOL","LU0210528500.USD","LU0308772762.SGD","LU0882574055.USD","HK0000306701.USD","LU0456855351.SGD","LU0672654240.SGD","LU0006306889.USD","LU0320765059.SGD","LU2028103732.USD","LU2047632596.USD","BK4504","BK4561","LU0466842654.USD","LU2420271590.USD","LU2458330243.SGD","IE00B19Z9P08.USD","IE0004086264.USD","LU0143863784.USD","LU2471134523.USD","LU2087625088.SGD","LU0949170426.SGD","LU0058720904.USD","LU0289961442.SGD","LU1979441026.SGD","LU1291159041.SGD","LU0823434740.USD","IE00BZ1G4Q59.USD","LU0211326839.USD","LU1267930730.SGD","LU1223082519.USD","IE00B7KXQ091.USD","IE00B775H168.HKD","SG9999001176.USD","LU0203202063.USD","BK4553","LU1854103824.USD","JETS","DSPC","AU","LU2552382215.SGD","RXL","LU0788108826.HKD","LU1934455277.USD","HK0000532082.HKD","LU0048584097.USD","LU0211326755.USD","LU2191332357.HKD","SG9999018865.SGD","IE00BN29S564.USD","LU0498741890.SGD","LU0330918003.SGD","LU2023250504.SGD","LU1003077747.HKD","LU1400636657.SGD","LU0784384876.USD","IE00BFMHRM44.USD","LU1935043023.USD","LU0203345920.USD","BK4550","LU1582986359.USD","BK4554","AAPD","LU2954938101.SGD","LU2271345857.HKD","IE00B5949003.HKD","LU0075056555.USD","SG9999014021.USD","BK4581","LU0444973449.USD","SG9999001424.SGD","SGXZ51526630.SGD","LU0278409577.USD","LU0251132253.USD","IE00B3S45H60.SGD","IYF","METV","LU0345768153.USD","LU0456854461.SGD","LU2168564222.USD","LU1551013342.USD","IE00B4YYXB79.USD","LU1119994496.HKD","LU0345770308.USD","LU0107464264.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0823421416.USD","LU0612318385.USD","LU0976567544.SGD","IE0034235295.USD","LU2100268510.USD","LU1244550494.USD","AAPE","LU0795875086.SGD","WARP","IE00B7SZLL34.SGD","LU0820562030.AUD","LU1066051811.HKD","LU2430703178.SGD","IE00BMPRXQ63.HKD","IYG","BK4132","LU2461242641.AUD","LU1621768115.EUR","LU1894683264.USD","LU2756315318.SGD","LU0143863198.USD","LU2112291526.USD","LU1894683348.USD","LU0965509283.SGD","IE00BMPRXR70.SGD","LU0081259029.USD","LU0642271901.SGD","SG9999017495.SGD","LU0056508442.USD","TFNS","BK4507","BK4512","LU1868836591.USD","LU1868836914.USD","LU1732799900.SGD","AUMI","LU0055631609.USD","LU0077335932.USD","LU1791710582.SGD","LU0127658192.USD","LU0738911758.USD","LU0742534661.SGD","LU1989771016.USD","LU1261432733.SGD","LU2552382058.USD","LU2279689827.SGD","SG9999014559.SGD","IXN","HUM","LU2468319806.SGD","LU2054465674.USD","LU1674673691.USD","IE0000B7K699.USD","LU0082616367.USD","LU2360107168.USD","LU1069344957.HKD","AAPB","IE00BJJMRX11.SGD","LU2491050071.SGD","LU0557290698.USD","ORBX","IE00BJLML261.HKD","BK4017","GDOC","LU2106854487.HKD","LU2092627202.USD","IE0034235188.USD","LU2750360641.GBP","LU2098885051.SGD","IE0003U64NQ7.SGD","XLF","LU1127390331.HKD","TRUH","AAPW","SG9999014898.SGD","LU0079474960.USD","LU0211328371.USD","LU1267930573.SGD","BK4170","LU1670627923.USD","SPCM","LU1582987324.SGD","LU1861559042.SGD","BK4576","SG9999015358.SGD","IE00BJJMRZ35.SGD","BK4579","JGRO","LU2462157665.USD","LU2860962120.EUR","IE00BKVL7J92.USD","LU2089283258.USD","IE0001KFT4U8.USD","IE000ITXATA3.USD","LU2063271972.USD","LU0528227936.USD","IE0004445015.USD","LU1093756325.SGD","LU0316494557.USD","LU1989764748.USD","SG9999000418.SGD","LU0128525929.USD","SG9999014567.USD","LU0154236417.USD","LU0094547139.USD","LU3102509885.SGD","LU0823434583.USD","IE0004445239.USD","LU1935043452.HKD","LU2237443895.HKD","LU0106261372.USD","LU0323591593.USD","LU2023250330.USD","LU0784385170.HKD","LU0444971666.USD","LU1223083913.SGD","LU1244550577.SGD","LU0211331839.USD","LU0882574139.USD","LU1815333072.USD","LU1066051498.USD","BK4566","BK4089","AFK","LU0353189763.USD","IE000WAW04H5.SGD","LU2746668974.SGD","LU0203201768.USD","IE0009356076.USD","LU0345780281.USD","IE00BLSP4239.USD","LU2065170008.USD","MACW.SI","LU1670628061.USD","LU2361044949.HKD","LU2491049909.HKD","SSPC","LU2357627491.SGD","TRUF","LU0476273544.USD","LU1301847155.USD","IE00BZ9MQY76.HKD","LU1023059063.AUD","SPCF","BK4571","LU1621767810.EUR","SG9999001176.SGD","IE000W1ABFV2.USD","IE00BSNM7G36.USD","LU0496367417.USD","BK4527"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173333030","title":"摩根大通首次覆盖Definium Therapeutics给予增持评级，盘前股价应声上涨4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173333030","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173333030?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 17:32","pubTimestamp":1791538328,"startTime":"0","endTime":"0","summary":"摩根大通首次对Definium Therapeutics启动覆盖，给出增持评级，该股盘前随即上扬4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674830635","title":"Definium Therapeutics股价盘前上涨4%，此前摩根大通首次覆盖该股并给予增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2674830635","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674830635?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 17:31","pubTimestamp":1791538312,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PGF","BK4539","DFTX","BK4139","BK4007","LENZ","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667962699","title":"专家敦促美国食品药品监督管理局（FDA）为迷幻药物制定明确的安全和获取标准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667962699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667962699?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 06:39","pubTimestamp":1789425555,"startTime":"0","endTime":"0","summary":"此次听证会是美国总统唐纳德·特朗普政府自4月  以来，为推动合格的迷幻药物项目  进入市场所开展的、历时数月的最新举措。发言者敦促研究人员收集有关月经周期、妊娠及产后状况、围绝经期、绝经期、激素水平及合并用药的数据，并警告称汇总结果可能会掩盖疗效或不良事件方面的差异。“FDA对安全性和有效性的评估……必须始终是未来任何临床应用的基础，”美国精神病学协会表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4561NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139","BK4007","GHRS","DFTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145365920","title":"Definium Therapeutics股价盘前飙升20%，其LSD类抗焦虑药物在第二项晚期研究中再次取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=1145365920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145365920?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:33","pubTimestamp":1789385589,"startTime":"0","endTime":"0","summary":"Definium Therapeutics的股价在盘前交易中大幅上涨20%，这一跃升的背后，是该公司基于LSD研发的抗焦虑药物在第二项关键性后期临床试验中再次交出了积极答卷。此番捷报频传，无疑为市场注入了强心剂，投资者信心随之显著提振。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650759","title":"Definium公司基于LSD的药物在第二项成功的后期临床研究中降低了焦虑水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650759","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650759?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383636,"startTime":"0","endTime":"0","summary":"Definium公司基于LSD的药物在第二项成功的后期临床研究中降低了焦虑水平Kamal Choudhury/Puyaan Singh9月14日-Definium Therapeutics公司周一表示，其基于LSD的治疗方法在临床试验中减轻了广泛性焦虑障碍的症状，这使该公司针对该病症的晚期临床研究第二次取得成功。监管机构 和 投资者对迷幻类疗法的热情，推动 Definium 股价今年上涨近三倍。Definium称，疗效最早在治疗第二天就显现，并持续至第12周。Definium预计将于2027年上半年向美国食品药品监督管理局提交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4560QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174385904","title":"Definium Therapeutics：DT120口崩片III期全景研究在广泛性焦虑障碍中达成主要及关键次要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1174385904","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174385904?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383614,"startTime":"0","endTime":"0","summary":"Definium Therapeutics今日宣布，其评估DT120口崩片治疗广泛性焦虑障碍的III期PANORAMA研究，已成功达到主要终点及关键次要终点。这一里程碑式的成果，为该公司在焦虑症治疗领域的布局注入了强劲动力。Definium Therapeutics表示，详细的完整研究数据将在即将召开的医学会议上进行展示，并计划基于这些发现，积极与美国食品药品监督管理局等监管机构沟通，推进该药物的注册上市进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107633829","title":"Definium Therapeutics：DT120口腔崩解片100微克总体耐受性良好，安全性特征一致，未现新型安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1107633829","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107633829?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383611,"startTime":"0","endTime":"0","summary":"Definium Therapeutics近日公布，其研发的DT120口腔崩解片在100微克剂量下展现出总体良好的耐受性。值得注意的是，该药物的安全性特征保持高度一致性，且未出现任何新型安全信号。在临床观察中，受试者对DT120 Odt 100 Mcg的接受度令人鼓舞。Definium Therapeutics的这项发现，不仅印证了该候选药物的潜在价值，同时也为后续更深入的临床研究奠定了坚实基础。安全性特征的一致性，往往意味着更高的可预测性和更低的开发风险。眼下，公司正积极推进该药物的进一步评估工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148441427","title":"Definium Therapeutics：DT120口崩片100微克在12周时显示安慰剂校正的汉密尔顿焦虑量表评分降低5.1分","url":"https://stock-news.laohu8.com/highlight/detail?id=1148441427","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148441427?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383609,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其候选药物DT120口崩片（Odt）在100微克剂量下，于治疗第12周时展现出了显著的抗焦虑疗效。具体数据显示，与安慰剂相比，该药物使患者的汉密尔顿焦虑量表评分平均降低了5.1分，这一结果具有临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160872994","title":"Definium Therapeutics将于2026年9月14日公布泛发性焦虑障碍III期Panorama研究的关键结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1160872994","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160872994?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 05:00","pubTimestamp":1789333236,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，计划于2026年9月14日召开会议，重点讨论其在泛发性焦虑障碍（GAD）领域所进行的III期Panorama研究的顶线结果。这一备受关注的数据发布，将为该候选疗法的疗效与安全性提供关键性证据。公司方面表示，此次披露的结果有望为后续的监管申报及临床开发路径奠定坚实基础。业界普遍预期，这一研究数据不仅关乎Definium自身的管线价值，也可能对整个焦虑障碍治疗领域产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375780","title":"Definium因抑郁症药物获FDA“突破性疗法”认定而股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375780","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375780?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 21:59","pubTimestamp":1788875957,"startTime":"0","endTime":"0","summary":"BUZZ-Definium因抑郁症药物获FDA“突破性疗法”认定而股价上涨9月8日-** Definium Therapeutics（DFTX.O）股价上涨2.2%，至38.92美元** 该公司表示，其基于LSD的实验性药丸DT120 (link) 获得美国食品药品监督管理局（FDA）授予的突破性疗法认定，用于治疗重度抑郁症（MDD）** “突破性疗法”认定旨在加速针对严重疾病或存在未满足医疗需求","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45014Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168482991","title":"Definium Therapeutics 重磅消息：DT120（麦角酸二乙胺）口崩片获突破性疗法认定，三期临床数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1168482991","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168482991?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 19:01","pubTimestamp":1788865279,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 迎来重大里程碑——该公司研发的 DT120口腔崩解片，在针对重度抑郁症的治疗中取得积极三期临床试验结果后，成功获得美国食品药品监督管理局授予的突破性疗法认定。突破性疗法认定是FDA为加速严重或危及生命疾病的药物研发与审查而设立的特别通道，旨在确保患者能够尽快获得有前景的新疗法。展望未来，Definium Therapeutics 将有望凭借这一认定的政策优势，与FDA展开更密切的沟通协作，力求大幅缩短药物从研发到上市的时间周期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659909279","title":"市场快讯——美股行情动态-Sutro Biopharma、Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659909279","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659909279?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 00:18","pubTimestamp":1786551516,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI持平于53,793.87点。标普500指数.SPX上涨0.22%，报7,745.57点；纳斯达克综合指数.IXIC上涨0.47%，报26,569.32点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4T4491DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA","SLN","LOCL","UFO","TPL","CAVA","OFAL","DFTX","DPRE","NCMI","GAP","CRWV","EROC","TSHA","BIVI","NBIS","CHTR","ALT","SRHR","NBIL","O","EAT","STRO","SVV","SLNCF","FSLR","FRNW","HRB","LAZR","HUMA","ANNX","UAMY","OPLN","NBIX","CIEN","SMWB","TRMB","TECH","ABSI","SMMT","RSPG","SLXN","NTHI","LITX","PFGC","BETA","LUMA","WXM","LITE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192985516","title":"Definium Therapeutics 焦虑症药物晚期试验达标，盘前股价飙升 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192985516","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192985516?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:45","pubTimestamp":1786535108,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 的股价在盘前交易时段猛涨22%，原因在于该公司针对焦虑症的一款药物成功达成了后期临床试验的核心目标。这一喜讯瞬间点燃了市场热情，投资者纷纷涌入，推动股价大幅上扬。此次试验结果无疑为这家生物技术公司注入了强劲的发展动力，也为其在精神健康领域的布局增添了关键砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658744709","title":"Definium Therapeutics股价上涨，因其治疗焦虑症的药物达到了后期临床试验的目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2658744709","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658744709?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:43","pubTimestamp":1786535004,"startTime":"0","endTime":"0","summary":"BUZZ-Definium Therapeutics股价上涨，因其治疗焦虑症的药物达到了后期临床试验的目标8月12日-** 生物技术公司 Definium Therapeutics（DFTX.O）的股价在盘前交易中上涨 22.2%，至 50.01 美元** 该公司 (link) 表示，在一项晚期临床研究中，其基于LSD的实验性口服药显著减轻了广泛性焦虑障碍（GAD）成年患者的焦虑症状，达到了试验的","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","BK0123","BK0214","600776","BK0010","BK0167","BK0012","BK0090","DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143492874","title":"Definium Therapeutics 宣布DT120 Odt针对广泛性焦虑障碍的3期Voyage研究取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1143492874","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143492874?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:01","pubTimestamp":1786532478,"startTime":"0","endTime":"0","summary":"Definium Therapeutics（DFTX）今日发布重磅消息：其针对广泛性焦虑障碍的DT120 Odt，在3期Voyage研究中录得积极的顶线数据。该研究结果令人振奋，为这款在研疗法带来了新曙光。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168532165","title":"Definium Therapeutics：DT120 Odt 三期Voyage研究达成主要及关键次要疗效终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1168532165","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168532165?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:01","pubTimestamp":1786532471,"startTime":"0","endTime":"0","summary":"Definium Therapeutics宣布，其关键药物DT120 Odt的三期临床试验Voyage研究已成功达成主要及关键次要疗效终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971366","title":"Definium公司表示，基于LSD的药片在晚期临床试验中可缓解焦虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971366","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971366?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532446,"startTime":"0","endTime":"0","summary":"Definium公司表示，基于LSD的药片在晚期临床试验中可缓解焦虑路透8月12日-Definium Therapeutics公司周三表示，其基于LSD的实验性药片在一项晚期研究中显著减轻了焦虑症状，达到了试验的主要目标。该公司表示，经安慰剂校正后的5.4分差异在统计学上显著且具有临床意义。监管机构 以及投资者对迷幻类疗法的热情 ，推动Definium股价今年迄今已上涨逾三倍。此次试验是Definium公司针对DT120取得的第二项晚期临床试验成功，此前该公司在6月公布了一项抑郁症研究的积极结果 。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4T4490RK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103074392","title":"Definium Therapeutics：DT120 Odt 在研究中总体耐受性良好，未出现包括自杀倾向信号在内的新安全性信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1103074392","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103074392?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532410,"startTime":"0","endTime":"0","summary":"Definium Therapeutics 宣布，其药物 DT120 Odt 在一项临床研究中展现出总体良好的耐受性。研究未发现任何新的安全性信号，其中尤为关键的是，没有监测到自杀倾向相关的信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}